Inflammatory mediators, tumor necrosis factor-α and interferon-γ, induce EMT in human PTC cell lines

Oncology Letters

Volumn 10, Issue 4, 2015, Pages 2591-2597

  Lv, Nannan ^a   Gao, Yun ^b   Guan, Haixia ^a   Wu, Dan ^a   Ding, Shuangning ^a   Teng, Weiping ^a   Shan, Zhongyan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b He Eye Industry Group Co LTD   (China)

Author keywords

Epithelial mesenchymal transition; Inflammation; Invasion; Migration; Papillary thyroid cancer

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CARCINOMA; UPREGULATION;

EID: 84940061792     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.3518     Document Type: Article

References (37)

1. Davies L and Welch HG: Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295: 2164-2167, 2006.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
3. Guan HX, Shan ZY, Mi XY, Wang E and Teng W: Incidence of thyroid carcinoma before and after universal salt iodization: An 11-year retrospective analysis of pathological reports. J Chin Med Univ 35: 284-285, 2006.
4. Liu YQ, Zhang SQ, Chen WQ, Chen LL, Zhang SW, Zhang XD and Zheng RS: Trend of incidence and mortality on thyroid cancer in China during 2003-2007. Zhonghua Liu Xing Bing Xue Za Zh 33: 1044-1048, 2012 (In Chinese).
5. Wu ST, Sun GH, Hsu CY, Huang CS, Wu YH, Wang HH and Sun KH: Tumor necrosis factor-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism. Exp Biol Med (Maywood) 236: 1022-1029, 2011.
6. Liotti F, Visciano C and Melillo RM: Inflammation in thyroid oncogenesis. Am J Cancer Res 2: 286-297, 2012.
7. Menicali E, Moretti S, Voce P, Romagnoli S, Avenia N and Puxeddu E: Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinoma. Front Endocrinol (Lausanne) 3: 67, 2012.
8. Aust G, Heuer M, Laue S, Lehmann I, Hofmann A, Heldin NE and Scherbaum WA: Expression of tumour necrosis factor-alpha (TNF-α) mRNA and protein in pathological thyroid tissue and carcinoma cell lines. Clin Exp Immunol 105: 148-154, 2006.
9. Bossowski A, Harasymczuk J, Moniuszko A, Bossowska A, Hilczer M and Ratomski K: Cytometric evaluation of intracellular IFN-γ and IL-4 levels in thyroid follicular cells from patients with autoimmune thyroid diseases. Thyroid Res 4: 13, 2011.
10. Jing Y, Han Z, Liu Y, Sun K, Zhang S, Jiang G, Li R, Gao L, Zhao X, Wu D, et al: Mesenchymal stem cells in inflammation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition. PloS One 7: e43272, 2012.
11. Wang H, Wang HS, Zhou BH, Li CL, Zhang F, Zhang G, Bu XZ, Cai SH and Du J: Epithelial-mesenchymal transition (EMT) induced by TNF-a requires AKT/GSK-3b-mediated stabilization of snail in colorectal cancer. PLoS One 8: e56664, 2013.
12. Knauf JA, Sartor MA, Medvedovic M, et al: Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling. Oncogene 30: 3153-3162, 2011.
13. Sancisi V, Gandolfi G, Ragazzi M, Nicoli D, Tamagnini I, Piana S and Ciarrocchi A: Cadherin 6 is a new RUNX2 target in TGF-β signalling pathway. PloS One 8: e75489, 2013.
14. Valastyan S and Weinberg RA: Tumor metastasis: Molecular insights and evolving paradigms. Cell 147: 275-292, 2011.
15. Howard EW, Camm KD, Wong YC and Wang XH: E-cadherin upregulation as a therapeutic goal in cancer treatment. Mini Rev Med Chem 8: 496-518, 2008.
16. Bai Y, Kakudo K, Nakamura M, Ozaki T, Li Y, Liu Z, Mori I, Miyauchi A and Zhou G: Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma and periostin expression. Cancer Lett 281: 188-195, 2009.
17. Vasko V, Espinosa AV, Scouten W, He H, Auer H, Liyanarachchi S, Larin A, Savchenko V, Francis GL, de la Chapelle A, et al: Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci USA 104: 2803-2808, 2007.
18. Liu Z, Kakudo K, Bai Y, Li Y, Ozaki T, Miyauchi A, Taniguchi E and Mori I: Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition. J Clin Pathol 64: 325-329, 2011.
19. Puppin C, Fabbro D, Dima M, Di Loreto C, Puxeddu E, Filetti S, Russo D and Damante G: High periostin expression correlates with aggressiveness in papillary thyroid carcinomas. J Endocrinol 197: 401-408, 2008.
20. Braun J, Hoang V, Dralle H and Hüttelmaier S: Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene 29: 4237-4244, 2010.
21. Grände M, Franzen Å, Karlsson JO, Ericson LE, Heldin NE and Nilsson M: Transforming growth factor-β and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J Cell Sci 115: 4227-4236, 2002.
22. Ren J, Wang Y, Gao Y, Mehta SB and Lee CG: FAT10 mediates the effect of TNF-α in inducing chromosomal instability. J Cell Sci 124: 3665-3675, 2011.
23. Shiozaki A, Bai X, Shen T, Moodley S, Takeshita H, Fung SY, Wang Y, Keshavjee S and Liu M: Claudin 1 mediates TNFα-induced gene expression and cell migration in human lung carcinoma cells. PLoS One 7: e38049, 2012.
24. Borthwick LA, Gardner A, De Soyza A, Mann DA and Fisher AJ: Transforming growth factor-β1 (TGF-β1) driven epithelial to mesenchymal transition (EMT) is accentuated by tumour necrosis factor α (TNFα) via crosstalk between the SMAD and NF-κB pathways. Cancer Microenviron 5: 45-57, 2012.
25. López-Novoa JM and Nieto MA: Inflammation and EMT: An alliance towards organ fibrosis and cancer progression. EMBO Mol Med 1: 303-314, 2009.
26. Lo HW, Hsu SC, Xia W, Cao X, Shih JY, Wei Y, Abbruzzese JL, Hortobagyi GN and Hung MC: Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 67: 9066-9076, 2007.
27. Xue H, Wang W, Li Y, Shan Z, Li Y, Teng X, Gao Y, Fan C and Teng W: Selenium upregulates CD4+CD25+ regulatory T cells in iodine-induced autoimmune thyroiditis model of NOD H-2h4 mice. Endocr J 57: 595-601, 2010.
28. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY and Weinberg RA: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715, 2008.
29. Liu J and Brown R: Immunohistochemical detection of epithelial mesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma. Int J Clin Exp Pathol 3: 755-762, 2010.
30. Fagman H, Grande M, Edsbagge J, Semb H and Nilsson M: Expression of classical cadherins in thyroid development: Maintena-nce of an epithelial phenotype throughout organogenesis. Endocrinology 144: 3618-3624, 2003.
31. Jensen K, Patel A, Hoperia V, Larin A, Bauer A and Vasko V: Dynamic changes in E-cadherin gene promoter methylation during metastatic progression in papillary thyroid cancer. Exp Ther Med 1: 457-462, 2010.
32. Rocha A, Soares P, Seruca R, Máximo V, Matias-Guiu X, Cameselle-Teijeiro J and Sobrinho-Simões M: Abnormalities of the E-adherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. J Pathol 194: 358-366, 2001.
33. Ulianich L, Garbi C, Treglia A, Punzi D, Miele C, Raciti GA, Beguinot F, Consiglio E and Di Jeso B: ER stress is associated with dedifferentiation and an epithelial-to-mesenchymal transition-like phenotype in PC Cl3 thyroid cells. J Cell Sci 121: 477-486, 2008.
34. Huber MA, Kraut N and Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558, 2005.
35. Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi J, Nevo J, Gjerdrum C, Tiron C, Lorens JB and Ivaska J: Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 30: 1436-1448, 2011.
36. Mendez MG, Kojima S and Goldman RD: Vimentin induces changes in cell shape, motility and adhesion during the epithelial to mesenchymal transition. FASEB J 24: 1838-1851, 2010.
37. Kokkinos MI, Wafai R, Wong MK, Newgreen DF, Thompson EW and Waltham M: Vimentin and epithelial-mesenchymal transition in human breast cancer-observations in vitro and in vivo. Cells Tissues Organs 185: 191-203, 2007.